Continued lack of interest for this company........just reinforces the tremendous need to go full throttle in developing/launching a comprehensive Investor relations plan asap for North America. Should have been launched/or started with the permission of the BLA submission being granted by the FDA imo. Add, upcoming analyst reports, focused positioning under new Telesta Therapeutics banner/brand, insights from 3rd party U.S. commercial assessment for MCNA near completion (hopefully partially communicated to investment world), BLA filing on target for Q1-15 and a potential partner for MCNA...and no lack of information to share to end Q4-14 and start 2015. And, no lack of sp catalysts here, in varying degree. Need to restore confidence with existing shareholders and much more important, build a new investor base on Telesta/MCNA potential (not on a bargain basement sp financing with warrants). Enjoy a warmer wk-end ahead! rg FYI...interesting wk-end reading...." Investment Banker D. Huebner on How to Uncover Micro-Cap Biotechs that Deliver on Promises" (20/11/14) https://www.thelifesciencesreport.com/pub/na/16348?utm_source=delivra&utm_medium=email&utm_campaign=TLSR+final+11%2D20%2D14